ciclopirox has been researched along with Carcinoma, Renal Cell in 1 studies
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Von Schulz-Hausmann, SA | 1 |
| Schmeel, LC | 1 |
| Schmeel, FC | 1 |
| Schmidt-Wolf, IG | 1 |
1 other study available for ciclopirox and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Targeting the Wnt/beta-catenin pathway in renal cell carcinoma.
Topics: beta Catenin; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Survival; Ciclopirox; Drug Combinations; | 2014 |